ArticlePDF Available

Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months

Authors:

Abstract

MRC CRASH is a randomised controlled trial (ISRCTN74459797) of the effect of corticosteroids on death and disability after head injury. We randomly allocated 10,008 adults with head injury and a Glasgow Coma Scale score of 14 or less, within 8 h of injury, to a 48-h infusion of corticosteroid (methylprednisolone) or placebo. Data at 6 months were obtained for 9673 (96.7%) patients. The risk of death was higher in the corticosteroid group than in the placebo group (1248 [25.7%] vs 1075 [22.3%] deaths; relative risk 1.15, 95% CI 1.07-1.24; p=0.0001), as was the risk of death or severe disability (1828 [38.1%] vs 1728 [36.3%] dead or severely disabled; 1.05, 0.99-1.10; p=0.079). There was no evidence that the effect of corticosteroids differed by injury severity or time since injury. These results lend support to our earlier conclusion that corticosteroids should not be used routinely in the treatment of head injury.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Final results of MRC CRASH, a randomised placebo-controlled trial of ...
Edwards, Phil;Arango, Miguel;Balica, Laura;Cottingham, Rowland;et al
The Lancet; Jun 4-Jun 10, 2005; 365, 9475; ProQuest Hospital Collection
pg. 1957
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
... The risk of death within 6 months with corticosteroid use was 25.7% vs. 22.3% with placebo (95% CI 1.07-1.24; p = 0.0001) [114]. Similar findings were present when comparing the corticosteroid group vs. placebo for risk of death or severe injury with 38.1% vs. 36.3%, ...
... respectively (95% CI 0.99-1.10; p = 0.079) [114]. When comparing subgroups, the effect of corticosteroids was not affected by the severity of the injury or the time of the injury [113]. ...
... Roberts et al. [113] Edwards et al. [114] Trials showed an increased risk of death or severe disability in the group of patients who received steroids compared to controls. Kostron et al. [120] Xiong et al. [70] Langham et al. [121] Despite their use in clinical practice to attempt to prevent secondary injury, a review of 6 randomized control trials demonstrated no statistically significant benefit of calcium channel blockers in reducing death and severe disability in TBI patients. ...
Article
Full-text available
Traumatic brain injury is one of the leading causes of morbidity and mortality worldwide and is one of the major public healthcare burdens in the US, with millions of patients suffering from the traumatic brain injury itself (approximately 1.6 million/year) or its repercussions (2–6 million patients with disabilities). The severity of traumatic brain injury can range from mild transient neurological dysfunction or impairment to severe profound disability that leaves patients completely non-functional. Indications for treatment differ based on the injury’s severity, but one of the goals of early treatment is to prevent secondary brain injury. Hemodynamic stability, monitoring and treatment of intracranial pressure, maintenance of cerebral perfusion pressure, support of adequate oxygenation and ventilation, administration of hyperosmolar agents and/or sedatives, nutritional support, and seizure prophylaxis are the mainstays of medical treatment for severe traumatic brain injury. Surgical management options include decompressive craniectomy or cerebrospinal fluid drainage via the insertion of an external ventricular drain. Several emerging treatment modalities are being investigated, such as anti-excitotoxic agents, anti-ischemic and cerebral dysregulation agents, S100B protein, erythropoietin, endogenous neuroprotectors, anti-inflammatory agents, and stem cell and neuronal restoration agents, among others.
... Despite the lack of convincing RCT data for efficacy, IVMP remains in common usage internationally [36]. The CRASH study, published in 2005 recruited 10,008 patients examined within less than 8 h after TBI, randomising them to placebo or 11.6 g intravenous methylprednisolone over the first 24 h, followed by 21.2 g over the second 48 h [37]. Patients were more likely to have an outcome of death and the composite outcome of death or severe disability when treated with corticosteroids than with placebo. ...
... Patients were more likely to have an outcome of death and the composite outcome of death or severe disability when treated with corticosteroids than with placebo. That detrimental difference in outcome was qualitatively greater in patients with moderate TBI than in patients with severe TBI, and with increasing time since injury [37]. ...
Article
Full-text available
Background Traumatic optic neuropathy is classically described in up to 8% of patients with traumatic brain injury (TBI), but subclinical or undiagnosed optic nerve damage is much more common. When more sensitive testing is performed, at least half of patients with moderate to severe TBI demonstrate visual field defects or optic atrophy on examination with optical coherence tomography. Acute optic nerve compression and ischaemia in orbital compartment syndrome require urgent surgical and medical intervention to lower the intraocular pressure and diminish the risk of permanent optic nerve dysfunction. Other manifestations of traumatic optic neuropathy have more variable treatments in international practice. Methods We conducted a systematic review of traumatic optic neuropathy treatments in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. Results We included three randomised controlled trials of intravenous methylprednisolone (IVMP), erythropoietin, and levodopa-carbidopa combination, with no evidence of benefit for any treatment. In addition, large studies in TBI have found strong evidence of increased mortality in patients treated with megadose IVMP. Conclusions There is therefore no evidence of benefit for any medical treatment and strong evidence of harm from IVMP. There is also no evidence of benefit for optic canal decompression for traumatic optic neuropathy. Orbital compartment syndrome is a separate entity that requires both medical and surgical interventions to prevent visual loss.
... Reasons for this disparity may include differences between animal models and humans, challenges in replicating human heterogeneity, poorly designed trials, and the limitations of targeting single nodes in immune regulation. [59][60][61][62][63] Sepsis is a major concern in trauma patients, accounting for 10% of trauma-related deaths. 57 Defined as life-threatening organ dysfunction triggered by a dysregulated host response to infection, sepsis imposes substantial healthcare costs and mortality rates in ICU. ...
Article
Full-text available
Severe trauma is a critical aspect of medical practice, profoundly impacting patient care and outcomes. Over the past 20 years, advancements in trauma care concepts and the utilization of advanced technologies have led to substantial growth in severe trauma research, evidenced by a notable increase in research activity and subsequent publications. To understand the publication landscape in severe trauma, identify prevailing research trends, and highlight areas requiring further development for future insights, we conducted a bibliometric analysis. Our analysis indicates that there are 16,939 severe trauma‐related publications from the past 20 years, with a continuous increase in publication volume, particularly showing a rapid growth trend from 2018 to 2021. The United States leads in both volume and citation frequency. Moreover, we synthesized data on productive countries/regions and research institutions, showcasing extensive collaboration across diverse geographic locations and institutional affiliations. Substantial progress has been achieved in severe trauma research, particularly in clinical diagnosis, treatment, epidemiology, prevention, and pathogenesis. However, there is still a gap in adopting cutting‐edge interdisciplinary methodologies. This study provides a comprehensive overview of the current state of severe trauma research and suggests pathways for future advancement.
Article
Aim: This paper aims to elucidate the key changes and insights from the 2023 European Society of Cardiology (ESC) guidelines for prehospital management of Acute Coronary Syndromes (ACS). Material and methods: The guidelines are thoroughly analyzed, focusing on diagnostic tools, treatment strategies, and pharmacological interventions. Specific attention is given to the utilization of electrocardiogram (ECG) in ACS diagnosis, oxygen therapy thresholds, the use of nitrates and contraindications, morphine and alternative pain management, aspirin administration, and the application of beta-blockers and benzodiazepines. Results: The guidelines emphasize the critical role of the 12-lead ECG in early ACS diagnosis, categorizing patients based on ST-segment elevation. Revised oxygen supplementation protocols and cautious use of nitrates are highlighted, considering their potential harmful effects. Alternatives to morphine for pain management and the importance of prompt aspirin administration are stressed. The guidelines also advocate for the use of intravenous beta-blockers in certain patients and recognize the role of benzodiazepines in managing stress-related symptoms. The importance of rapid treatment in reperfusion strategies and the use of ECG telemetry in enhancing communication with medical facilities are underscored. Conclusions: The 2023 ESC guidelines present a comprehensive and updated approach to the prehospital management of ACS. They emphasize the need for rapid and accurate diagnosis, judicious use of pharmacological interventions, and the importance of standardized care protocols. These guidelines are pivotal in improving patient outcomes, reducing mortality and morbidity, and necessitate continued education and adaptation by emergency medical personnel.
Article
Craniocerebral injuries are one of the causes of mortality in the population around the world. It is estimated that the frequency of their occurrence in highly developed countries is in the range of 200 per 100 000 people per year. According to the Brain Trauma Foundation, approximately 1.5 million of craniocerebral injuries are reported in the US annually. These injuries occur as a result of a direct impact and indirectly as a result of violent accelerating or braking forces acting on the brain. These forces are referred to as deceleration and acceleration. Traumatic Brain Injury (TBI) is difficult to determine with certainty, but 400 per 100 000 patients per year (range of 88 – 1967) have been reported, or ap¬proximately 1.4 million patients per year in the UK. TBI is the leading cause of death among adults under the age of 45 and in children (1-15 years old). Most TBIs are classified as mild, and about 8-10% are classified as moderate or severe.
Article
Aim: Pain accompanies a large proportion of patients being taken care of by emergency medical teams (EMT). The catalogue of available medications ex¬tended to 45 positions from the previously used 23, with the amount of analgesics available doubling from 4 to 8.The purpose of the study is to answer the following questions: 1. What types of pain do patients report as most severe and for what types of pain do patients receive the most appropriate management in the prehospital setting? 2. Have changes in medical documentation and the introduction of mandatory pain intensity assessment affected the quality of prehospital pain management? 3. What changes have occurred in the use of analgesics during the study period? Material and methods: An analysis of medical documentation was performed in the months of September 2016, September 2017 and June 2020. Re¬spectively 688, 996 and 798 EMT medical cards were included. Inclusion criteria incorporated the following ICD-10 codes: M54, G54, R51, R52, R07, I21, R10, N20-N23, K80-K83, S10-S99, T00-T14, T20-T32. Results: Stenocardia was observed to have a lower severity compared to other types of pain (p<0,001). On the other hand, visceral pain was found to possess a greater intensity when compared to post-traumatic pain (p<0,001). An increase in the use of various drugs’ combinations and opioids was also noted. We observed that both metamizole and paracetamol have also seen increased use at the expense of ketoprofen (p<0,001). Conclusions: 1.In emergency medical teams in Silesia, patients suffering from visceral pain claimed the highest initial pain levels. However, prehospital analgesia in those patients was the greatest. EMT swere also effective in post-traumatic pain management.2.Introducing good practices coupled with the requirement for EMTs to evaluate pain intensity in medical documentation had a positive effect on prehospital analgesia in selected emergency medical teams in Silesia.3.In selected silesian EMTs advantageous changes in prehospital analgesia were observed, including the diminishing use of NSAIDs which are being replaced by metamizole and paracetamol and an increase in opioid drugs’ use.
Article
This article examines the Polish State Emergency Medical System (PRM), focusing on its current state, legal regulations, and operational challenges. It discusses the structure of emergency teams, the qualifications of medical personnel, and the implementation of collaborative models like the rendez-vous system. The article identifies significant issues such as the shortage of emergency medicine specialists and financial constraints faced by hospital emergency departments. Furthermore, this study delves into the impact of technological advancements on the PRM, highlighting how digital innovation can streamline emergency response and patient care processes. Additionally, it addresses the integration of international best practices into the PRM and the potential benefits of such an approach. It also explores proposed changes aimed at enhancing the efficiency and effectiveness of the PRM, including reforms in team composition and career development opportunities for medical professionals. The analysis underscores the need for continuous updates to the system in response to evolving medical practices and societal needs.
Article
Safety at work and the health protection of employees hold a significant place in Poland’s social policy. Emergency medical teams (EMTs) are particularly ex¬posed to psychosocial hazards, especially psychological and physical aggression, while performing their duties. The impact of psychosocial hazards on medical rescuers can have negative consequences on both their mental and physical health. The work environment of medical rescuers, characterized by an increased risk of psychosocial factors, can lead to deterioration in the physical and mental health of these professionals. As a result, there is an increase in sick leave and a tendency to resign from their jobs. The consequences of exposing workers to psychosocial risks for their health depend on various factors, including the work environment, the type of economic activity, the technology used, and compliance with workplace safety and hygiene regulations. To minimize the negative impact on employees’ health, there is a need for continuous monitoring of the work environment to eliminate or reduce potential psychosocial threats. Fur¬thermore, it is essential to implement corrective actions and remedial measures at every stage of the work process to create a more conducive environment for the health and well-being of employees. Understanding these threats and the available management tools can help take more effective care of the well-being and mental health of medical rescuers, ultimately reflecting in the quality of healthcare services they provide. In the near future, it is crucial to raise awareness and approach the issue of psychosocial hazards in the work of EMTs.
Article
Full-text available
Aim: To analyse the level of knowledge of ambulance drivers on the rights and responsibilities associated with driving a priority vehicle. Material and methods: A survey was conducted in the first quarter of 2023 among 112 ambulance drivers. The main criterion for inclusion in the survey was the possession of a permit to drive a priority vehicle. Results: The level of ambulance drivers’ knowledge on the rights and responsibilities associated with driving a priority vehicle is high. 98.2% consider that they know the road traffic regulations, while 53.6% always and 43.8% often comply with them. Conclusions: Ambulance drivers know their rights and responsibilities when driving priority vehicles and mostly comply with road traffic regulations. They seek the causes of dangers in road traffic mainly in other participants, even though they do not always follow the regulations themselves. They are willing to improve their driving technique in additional priority vehicle driving courses.
ResearchGate has not been able to resolve any references for this publication.